CellSeed Inc (CellSeed) is a developer of regenerative medicine. The company’s products include epithelial cell sheet for corneal regeneration, regenerated cardiac patch, epithelial cell sheet for esophageal regeneration, cell sheet for periodontal tissue regeneration and regenerated cartilage sheet. It provides temperature-responsive cell cultureware for cell-sheet engineering, cell cutureware for cell collection and low cell binding cultureware. CellSeed’s UpCell finds application in tissue culture for regenerative medicine and for construction of 3D tissue. The company’s RepCell finds application in harvesting fragile cells such as stem cells and dendritic cells, and others. It also offers contract development and contract manufacturing services. The company has operations in Japan and Sweden. CellSeed is headquartered in Tokyo City, Japan.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Note: Some sections may be missing if data is unavailable for the company
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company CellSeed Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- CellSeed Inc Company Overview
- CellSeed Inc Company Snapshot
- CellSeed Inc Pipeline Products and Ongoing Clinical Trials Overview
- CellSeed Inc - Pipeline Analysis Overview
- CellSeed Inc - Key Facts
- CellSeed Inc - Major Products and Services
- CellSeed Inc Pipeline Products by Development Stage
- CellSeed Inc Ongoing Clinical Trials by Trial Status
- CellSeed Inc Pipeline Products Overview
- Cell Sheet - Liver Regeneration
- Cell Sheet - Liver Regeneration Product Overview
- Cell Sheet - Lung Regeneration
- Cell Sheet - Lung Regeneration Product Overview
- Cell Sheet - Middle Ear Regeneration
- Cell Sheet - Middle Ear Regeneration Product Overview
- Cell Sheet - Pancreas Regeneration
- Cell Sheet - Pancreas Regeneration Product Overview
- Cell Sheet - Periodontal Tissue Regeneration
- Cell Sheet - Periodontal Tissue Regeneration Product Overview
- Epithelial Cell Sheet - Corneal Regeneration
- Epithelial Cell Sheet - Corneal Regeneration Product Overview
- Epithelial Cell Sheet - Esophageal Regeneration
- Epithelial Cell Sheet - Esophageal Regeneration Product Overview
- Epithelial Cell Sheet - Esophageal Regeneration Clinical Trial
- Regenerated Cartilage Sheet
- Regenerated Cartilage Sheet Product Overview
- CellSeed Inc - Key Competitors
- CellSeed Inc - Key Employees
- CellSeed Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
Recent Developments
Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Takara Bio Inc
- Sato Pharmaceutical Co Ltd
- RaQualia Pharma Inc
- Carna Biosciences Inc
- Kissei Pharmaceutical Co Ltd